nk 252 has been researched along with dihydropyridines in 6 studies
| Studies (nk 252) | Trials (nk 252) | Recent Studies (post-2010) (nk 252) | Studies (dihydropyridines) | Trials (dihydropyridines) | Recent Studies (post-2010) (dihydropyridines) |
|---|---|---|---|---|---|
| 11 | 0 | 8 | 5,022 | 529 | 969 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Kiue, A; Kohno, K; Kuwano, M; Naito, A; Okumura, M; Sano, T | 1 |
| Inada, H; Kikuchi, J; Kiue, A; Kohno, K; Naito, A; Okumura, M; Sano, T; Sato, S; Suzuki, K; Takano, H | 1 |
| Kiue, A; Kohno, K; Kuwano, M; Takano, H; Watanabe, Y | 1 |
| Aoki, T; Asaoka, Y; Kaino, M; Mochizuki, H; Noda, H; Shimozono, R; Yamada, M; Yoshizawa, Y | 1 |
| Liu, J; Liu, S; Ta, N; Yang, Y | 1 |
| Chen, T; Cui, J; Gou, S; Guo, Y; Liang, X; Peng, T; Xiong, J | 1 |
6 other study(ies) available for nk 252 and dihydropyridines
| Article | Year |
|---|---|
Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Etoposide; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Male; Mice | 1991 |
Reversal by two dihydropyridine compounds of resistance to multiple anticancer agents in mouse P388 leukemia in vivo and in vitro.
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azides; Dactinomycin; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Leukemia P388; Male; Membrane Glycoproteins; Mice; Mice, Inbred Strains; Tritium; Vinblastine; Vincristine; Vindesine | 1990 |
Potentiation of etoposide and vincristine by two synthetic 1,4-dihydropyridine derivatives in multidrug-resistant and atypical multidrug-resistant human cancer cells.
Topics: Antineoplastic Agents; Cell Survival; Dihydropyridines; Dioxins; Drug Resistance; Drug Synergism; Etoposide; Humans; Intracellular Fluid; Neoplasms; Tritium; Tumor Cells, Cultured; Vincristine | 1991 |
Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Antioxidants; Binding Sites; Cell Line; Choline; Diet; Dihydropyridines; Dioxins; Disease Progression; Down-Regulation; Fatty Liver; Fibrosis; Gene Expression; Humans; Hydrogen Peroxide; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Liver; Male; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Transaminases; Up-Regulation | 2013 |
Inhibition of TLR2/TLR4 alleviates the Neisseria gonorrhoeae infection damage in human endometrial epithelial cells via Nrf2 and NF-Kβsignaling.
Topics: Apoptosis; Benzamides; Cell Survival; Cells, Cultured; Dihydropyridines; Dioxins; Down-Regulation; Endometritis; Endometrium; Epithelial Cells; Female; Gene Knockdown Techniques; Gonorrhea; Humans; Neisseria gonorrhoeae; NF-E2-Related Factor 2; Primary Cell Culture; Signal Transduction; Toll-Like Receptor 2; Toll-Like Receptor 4; Transcription Factor RelA | 2020 |
Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activating Nrf2/HO-1 Axis via Upregulating CCR2 Expression.
Topics: Aspartate Aminotransferase, Cytoplasmic; Dihydropyridines; Exosomes; Humans; Neoplastic Processes; Pancreatic Neoplasms; Receptors, CCR2 | 2022 |